906
Participants
Start Date
March 14, 2025
Primary Completion Date
January 31, 2029
Study Completion Date
April 30, 2029
Tenecteplase or Alteplase
Patients randomized to intravenous thrombolysis (IVT) treatment will receive intravenous Tenecteplase or Alteplase.
NOT_YET_RECRUITING
Academic Medical Center Amsterdam, Department of Neurology, Amsterdam
NOT_YET_RECRUITING
UZ Leuven, Leuven
RECRUITING
Inselspital Bern, Bern
NOT_YET_RECRUITING
University Hospital Basel, Basel
NOT_YET_RECRUITING
Canterbury District Health Board, Christchurch
NOT_YET_RECRUITING
"Attikon University Hospital", Athens
NOT_YET_RECRUITING
Heidelberg University Hospital, Heidelberg
NOT_YET_RECRUITING
GHU Paris Psychiatrie et Neurosciences, Sainte Anne, Paris
NOT_YET_RECRUITING
Hamilton Health Sciences, Hamilton
NOT_YET_RECRUITING
National Cerebral and Cardiovascular Center Osaka, Osaka
NOT_YET_RECRUITING
Akershus Hospital, Oslo
RECRUITING
Kantonsspital St. Gallen, Sankt Gallen
NOT_YET_RECRUITING
Lisbon Central University Hospital Centre, Lisbon
NOT_YET_RECRUITING
Vall d'Hebron Stroke Center, Barcelona
Insel Gruppe AG, University Hospital Bern
OTHER